Atux Iskay Group
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
303a College Rd E, Princeton, New Jersey...Website
www.atuxiskay.comRevenue
$5.2 MillionIndustry
About Atux Iskay Group
Is Atux Iskay Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Atux Iskay Group has new funding data
Check if Atux Iskay Group has recently received funding, and reach out quickly before it becomes old news!
Check out if Atux Iskay Group is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Atux Iskay Group recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Atux Iskay Group
Product Launch: Get notified when Atux Iskay Group launches new products
Click to see if Atux Iskay Group had a recent Job posting/layoffs
Atux Iskay Group, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Atux Iskay Group is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Atux Iskay Group is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Atux Iskay Group.
Atux Iskay Group Tech Stack
A closer look at the technologies used by Atux Iskay Group
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Atux Iskay Group
Atux Iskay Group, LLC is focused on developing small molecule modulators of the tumor suppressor phosphatase Protein Phosphatase 2A (PP2A), targeting therapeutic areas such as oncology, neurodegenerative diseases, and respiratory diseases. Their technology aims to normalize PP2A function, potentially impacting human health significantly. The compan... Read More